The REDUCE Follow-Up Study: Low Rate of New Prostate Cancer Diagnoses Observed During a 2-Year, Observational, Followup Study of Men Who Participated in the REDUCE Trial
Keywords: پادتن ویژه پروستات; dutasteride; prostatic neoplasms; diagnosis; biopsy; neoplasm grading5ARI, 5α-reductase inhibitor; PSA, prostate specific antigen; SAE, serious adverse event